Acute myocardial infarction (AMI) is a life-threatening medical condition, and it remains the primary reason for premature death (persons aged 25–64) worldwide. Therefore, early screening of cardiac biomarkers is critically important for improving survival chances. The existing methods for detecting cardiac biomarkers are multi-step approaches and require laboratory tests, which have higher test times, are […]
Read More